Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Guided Posters

Thyroid non cancer - Autoimmune Thyroid disease/pregnancy

ea0056gp255 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

MicroRNA-4443 causes CD4+T cells dysfunction by targeting TRAF4 in Graves’ disease

Qi Yicheng , Ning Guang , Wang Shu

Context: Aberrant CD4+T cell function plays a critical role in the process of Graves’ disease (GD). MicroRNAs (miRNAs) are important regulators of T cell activation, proliferation and cytokine production. However, the contribution of miRNAs to CD4+T cell dysfunction in GD remains unclear.Objective: To investigate how certain miRNA causes aberrant CD4+T cell function in GD patients.Methods: We compared the expression pattern of...

ea0056gp256 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Are Thyrotropin Receptor Antibodies (TRAb) being used to diagnose the aetiology of hyperthyroidism?

Desmond Chloe , Ahmad Aftab

Introduction: Hyperthyroidism is a prevalent condition which affects approximately 2% of the female population and 0.2% of the male population in the UK. 75% of cases are caused by the auto-immune condition, Graves’ disease. Thyrotropin receptor antibodies (TRAb) are raised in 90% of patients with Graves’ disease and are commonly used to investigate the aetiology of thyrotoxicosis.Background: TRAb can be used to confirm Graves’ disease due...

ea0056gp257 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value

Soldevila Berta , Hernandez Marta , Lopez Carolina , Cacenarro Laura , Martinez-Barahona Maria , Palomera Elisabet , Rius Ferran , Lecube Albert , Pelegay Maria Jose , Garcia Jordi , Mauricio Didac , Puig-Domingo Manel

Background: An association of pregnancy outcomes with subclinical hypothyroidism have been reported, however, there still exists a strong controversy regarding whether subclinical hypothyroidism ought to be dealt with or not. The latest American Thyroid Association’s guideline gives support to a higher TSH upper reference range of 4 mIU/l than the one proposed a few years ago of 2.5 mIU/l for the first trimester of pregnancy, in the absence of local normal ranges of TSH. ...

ea0056gp258 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Influence of levothyroxine treatment in pregnant women with thyroid antiperoxidase antibodies

Martinez Paula Fernandez , Garcia Rocio Aguado , Galindo David Emilio Barajas , Martinez Tania Ramos , Arnaiz Elena Gonzalez , Arias Sara Garcia , Ramos Mirian Alejo , Moreno Ana Hernandez , Pomar Maria Ballesteros , Rodriguez Isidoro Cano

Introduction: Thyroid antiperoxidase antibodies above the cut-off value (ATPO +) may increase the risk of maternal-foetal complications and could modify the treatment criteria. The aim of the study is to consider the impact of levothyroxine administration on maternal-foetal complications in ATPO+ pregnant women with delivery in 2016.Methods: In Leon’s health area (Spain), universal screening for gestational thyroid dysfunction is performed. ATPO + w...

ea0056gp259 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Thyroid disorders in patients with advanced neoplastic disease treated with immune checkpoints inhibitors

Fidilio Enzamaria , Velasquez Mayra A , Sanz Eva , Ortiz Angel M , Ciudin Andreea , Mesa Jorge , Zafon Carlos

The use of immune checkpoint inhibitors (ICPI) for treatment of different advanced cancers has opened a new therapeutic window. Thyroid dysfunction is an often side effect described for these drugs.Objectives: To describe the thyroid alterations found in oncologic patients undergoing treatment with ICPI.Materials and methods: A descriptive, retrospective study of oncologic patients receiving treatment with ICPI referred to the Endo...

ea0056gp260 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Early low dose rituximab for active thyroid eye disease: an effective and well tolerated treatment

Insull Elizabeth , Turner Helen , David Joel , Norris Jonathan

Background: Thyroid eye disease (TED) is an autoimmune inflammatory disease that can be both disfiguring and potentially sight threatening. Suppression of inflammation in active disease can reduce the risk of visual loss and limit long-term sequelae of the disease. Current disease management involves suppression of inflammation using glucocorticoids. The aim of our study was to evaluate the efficacy of early disease intervention with targeted immunomodulatory therapy to alter ...

ea0056gp261 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Analysis of serum immunoglobulin G4 (IgG4) levels in euthyroid subjects with autoimmune thyroid disease and goiter in a Single Medical Center in Taiwan

Wu Wan-Chen , Tseng Fen-Yu

Immunoglobulin G4-related disease (IgG4-RD) is a newly identified syndrome characterized by high serum IgG4 levels and increased IgG4-positive plasma cells infiltration. IgG4-related thyroiditis (IgG4-RT) was first prescribed based on the immunohistochemistry in 2009. Some of Hashimoto’s thyroiditis (HT), Graves’ disease (GD) and Riedel thyroiditis were reported to be classified as IgG4-RT based on high serum IgG4 level or histopathological findings. However, the pre...

ea0056gp262 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Thyroid disorders in patients treated with inmune checkpoint inhibition therapy

Eguilaz Nerea , Ernaga Ander , Anda Emma , Pineda Javier , Irigaray Ana , Zubiria Juan Manuel

Objective: Immune checkpoint inhibitors (ICPI) have become an effective therapeutic option for certain advanced malignant tumours. Immune-related adverse events affecting thyroid function are among the most frequent toxicities. The aim of our study is to determine the prevalence of thyroid disorders in patients undergoing treatment with ICPI.Methods: Retrospective study including all patients treated with ICPI in our centre, from 07/2015 to 12/2017. Pati...

ea0056gp263 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Thyroid peroxidase antibody-positivity, but not isolated thyroglobulin antibody-positivity, is associated with non-thyroidal autoimmune diseases - a population study of more than 8000 Danes

Bliddal Sofie , Pedersen Inge Bulow , Knudsen Nils , Carle Allan , Bjergved Lena , Nielsen Claus Henrik , Feldt-Rasmussen Ulla

Introduction: Autoimmune thyroid disease is associated with other autoimmune diseases. However, most studies are register-based cohort studies or investigate selected patient populations. In a large national cross-sectional population-based study, we investigated positivity of thyroid peroxidase- or thyroglobulin-antibodies (TPOAbs or TgAbs) in association with non-thyroidal autoimmune disease.Methods: As part of The Danish Investigation of Iodine Intake...

ea0056gp264 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)

Simeakis George , Vogiatzi Evangelia , Konstantakou Panagiota , Zapanti Evangelia , Saltiki Katerina , Alevizaki Maria , Anastasiou Eleni

Objectives: The interplay between thyroid function and metabolic state has been studied in many population subgroups. For pregnant women thyroid and metabolic parameters, including glucose homeostasis, are of great importance for a successful outcome. We examined aspects of thyroid function in relation to GDM and BMI in pregnant women referred to our Department.Methods: We studied 520 women during 24th – 32nd gestation week. De...